Robotic-assisted mitral valve repair: surgical technique

Khaled D. Algarni, Rakesh M. Suri, Richard C. Daly

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Robotic-assisted mitral valve repair represents the least invasive surgical approach currently available for anatomical mitral valve repair in patients with myxomatous mitral valve disease. Standard mitral valve repair techniques utilized during conventional sternotomy/right thoracotomy are exactly replicated with the robotic instrumentation through 1-2 cm port-like incisions with superior 3D visualization. This is performed on cardiopulmonary bypass by peripheral cannulation of the femoral vessels/right internal jugular vein. The ascending aorta is occluded with a transthoracic aortic cross-clamp. Antegrade cardioplegia is delivered centrally into the aortic root through a cardioplegia vent catheter. By replicating conventional mitral valve repair done via an open sternotomy approach, the quality of mitral valve repair is ensured while providing the patients with advantages of less invasive surgery including shorter hospital stay, rapid recovery and return to normal activities, less blood transfusion, superior cosmesis and complete elimination of sternotomy-related morbidities such as deep sternal wound infection and sternal dehiscence. We reviewed the first consecutive 200 patients undergoing robotic mitral valve repair at Mayo Clinic Rochester between 24 January 2008 and 28 January 2011. Successful mitral valve repair was completed in all patients. There were no early (30-day) deaths. One patient suffered a stroke (0.5%). One patient required reoperation for bleeding (0.5%). Two patients (1%) required reoperation for recurrent mitral regurgitation. Twelve patients (6%) required transfusion of allogeneic blood products. We have noted a significant reduction in operative times and resource utilization over time.

Fingerprint

Robotics
Mitral Valve
Sternotomy
Induced Heart Arrest
Reoperation
Blood Transfusion
Jugular Veins
Mitral Valve Insufficiency
Wound Infection
Thoracotomy
Operative Time
Thigh
Cardiopulmonary Bypass
Catheterization
Aorta
Length of Stay
Catheters
Stroke
Hemorrhage
Morbidity

Keywords

  • Minimally invasive
  • Mitral repair
  • Robotic assisted

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Robotic-assisted mitral valve repair : surgical technique. / Algarni, Khaled D.; Suri, Rakesh M.; Daly, Richard C.

In: Multimedia manual of cardiothoracic surgery : MMCTS / European Association for Cardio-Thoracic Surgery, Vol. 2014, 2014.

Research output: Contribution to journalArticle

@article{13b8fc4ad25348c2bb39fa188aa2f0dd,
title = "Robotic-assisted mitral valve repair: surgical technique",
abstract = "Robotic-assisted mitral valve repair represents the least invasive surgical approach currently available for anatomical mitral valve repair in patients with myxomatous mitral valve disease. Standard mitral valve repair techniques utilized during conventional sternotomy/right thoracotomy are exactly replicated with the robotic instrumentation through 1-2 cm port-like incisions with superior 3D visualization. This is performed on cardiopulmonary bypass by peripheral cannulation of the femoral vessels/right internal jugular vein. The ascending aorta is occluded with a transthoracic aortic cross-clamp. Antegrade cardioplegia is delivered centrally into the aortic root through a cardioplegia vent catheter. By replicating conventional mitral valve repair done via an open sternotomy approach, the quality of mitral valve repair is ensured while providing the patients with advantages of less invasive surgery including shorter hospital stay, rapid recovery and return to normal activities, less blood transfusion, superior cosmesis and complete elimination of sternotomy-related morbidities such as deep sternal wound infection and sternal dehiscence. We reviewed the first consecutive 200 patients undergoing robotic mitral valve repair at Mayo Clinic Rochester between 24 January 2008 and 28 January 2011. Successful mitral valve repair was completed in all patients. There were no early (30-day) deaths. One patient suffered a stroke (0.5{\%}). One patient required reoperation for bleeding (0.5{\%}). Two patients (1{\%}) required reoperation for recurrent mitral regurgitation. Twelve patients (6{\%}) required transfusion of allogeneic blood products. We have noted a significant reduction in operative times and resource utilization over time.",
keywords = "Minimally invasive, Mitral repair, Robotic assisted",
author = "Algarni, {Khaled D.} and Suri, {Rakesh M.} and Daly, {Richard C.}",
year = "2014",
doi = "10.1093/mmcts/mmu022",
language = "English (US)",
volume = "2014",
journal = "Multimedia manual of cardiothoracic surgery : MMCTS / European Association for Cardio-Thoracic Surgery",
issn = "1813-9175",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Robotic-assisted mitral valve repair

T2 - surgical technique

AU - Algarni, Khaled D.

AU - Suri, Rakesh M.

AU - Daly, Richard C.

PY - 2014

Y1 - 2014

N2 - Robotic-assisted mitral valve repair represents the least invasive surgical approach currently available for anatomical mitral valve repair in patients with myxomatous mitral valve disease. Standard mitral valve repair techniques utilized during conventional sternotomy/right thoracotomy are exactly replicated with the robotic instrumentation through 1-2 cm port-like incisions with superior 3D visualization. This is performed on cardiopulmonary bypass by peripheral cannulation of the femoral vessels/right internal jugular vein. The ascending aorta is occluded with a transthoracic aortic cross-clamp. Antegrade cardioplegia is delivered centrally into the aortic root through a cardioplegia vent catheter. By replicating conventional mitral valve repair done via an open sternotomy approach, the quality of mitral valve repair is ensured while providing the patients with advantages of less invasive surgery including shorter hospital stay, rapid recovery and return to normal activities, less blood transfusion, superior cosmesis and complete elimination of sternotomy-related morbidities such as deep sternal wound infection and sternal dehiscence. We reviewed the first consecutive 200 patients undergoing robotic mitral valve repair at Mayo Clinic Rochester between 24 January 2008 and 28 January 2011. Successful mitral valve repair was completed in all patients. There were no early (30-day) deaths. One patient suffered a stroke (0.5%). One patient required reoperation for bleeding (0.5%). Two patients (1%) required reoperation for recurrent mitral regurgitation. Twelve patients (6%) required transfusion of allogeneic blood products. We have noted a significant reduction in operative times and resource utilization over time.

AB - Robotic-assisted mitral valve repair represents the least invasive surgical approach currently available for anatomical mitral valve repair in patients with myxomatous mitral valve disease. Standard mitral valve repair techniques utilized during conventional sternotomy/right thoracotomy are exactly replicated with the robotic instrumentation through 1-2 cm port-like incisions with superior 3D visualization. This is performed on cardiopulmonary bypass by peripheral cannulation of the femoral vessels/right internal jugular vein. The ascending aorta is occluded with a transthoracic aortic cross-clamp. Antegrade cardioplegia is delivered centrally into the aortic root through a cardioplegia vent catheter. By replicating conventional mitral valve repair done via an open sternotomy approach, the quality of mitral valve repair is ensured while providing the patients with advantages of less invasive surgery including shorter hospital stay, rapid recovery and return to normal activities, less blood transfusion, superior cosmesis and complete elimination of sternotomy-related morbidities such as deep sternal wound infection and sternal dehiscence. We reviewed the first consecutive 200 patients undergoing robotic mitral valve repair at Mayo Clinic Rochester between 24 January 2008 and 28 January 2011. Successful mitral valve repair was completed in all patients. There were no early (30-day) deaths. One patient suffered a stroke (0.5%). One patient required reoperation for bleeding (0.5%). Two patients (1%) required reoperation for recurrent mitral regurgitation. Twelve patients (6%) required transfusion of allogeneic blood products. We have noted a significant reduction in operative times and resource utilization over time.

KW - Minimally invasive

KW - Mitral repair

KW - Robotic assisted

UR - http://www.scopus.com/inward/record.url?scp=84945465727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945465727&partnerID=8YFLogxK

U2 - 10.1093/mmcts/mmu022

DO - 10.1093/mmcts/mmu022

M3 - Article

C2 - 25362732

AN - SCOPUS:84945465727

VL - 2014

JO - Multimedia manual of cardiothoracic surgery : MMCTS / European Association for Cardio-Thoracic Surgery

JF - Multimedia manual of cardiothoracic surgery : MMCTS / European Association for Cardio-Thoracic Surgery

SN - 1813-9175

ER -